BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tidwell J, Balassiano N, Shaikh A, Nassar M. Emerging therapeutic options for non-alcoholic fatty liver disease: A systematic review. World J Hepatol 2023; 15(8): 1001-1012 [PMID: 37701920 DOI: 10.4254/wjh.v15.i8.1001]
URL: https://www.wjgnet.com/1948-5182/full/v15/i8/1001.htm
Number Citing Articles
1
Hazem Abosheaishaa, Mai Hussein, Muhammad Ghallab, Magdy Abdelhamid, Natalie Balassiano, Md Ripon Ahammed, Muhammad Almas Baig, Jawad Khan, Moaz Elshair, Moataz Yousry Soliman, Mohammed Abdelwahed, Amr Ali, Ahmed Alzamzamy, Mahmoud Nassar. Association between non-alcoholic fatty liver disease and coronary artery disease outcomes: A systematic review and meta-analysisDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2024; 18(1): 102938 doi: 10.1016/j.dsx.2023.102938
2
Hazem Abosheaishaa, Mahmoud Nassar, Omar Abdelhalim, Ammar Ayman Bahbah, Sharif Abbas, Samah M. Morsi, Muhammad Ghallab, Zakaria Alagha, Ahmed Omran, Khaled Elfert, Praneeth Bandaru, Arnold Nongmoh Forlemu, Madhavi Reddy. Relation between non-alcoholic fatty liver disease and carotid artery intimal media thickness as a surrogate for atherosclerosis: a systematic review and meta-analysisEuropean Journal of Gastroenterology & Hepatology 2024; 36(5): 592 doi: 10.1097/MEG.0000000000002721
3
Farah Khaznadar, Omar Khaznadar, Ana Petrovic, Marija Hefer, Fabian Gjoni, Stefan Gjoni, Justinija Steiner, Martina Smolic, Kristina Bojanic. MAFLD Pandemic: Updates in Pharmacotherapeutic Approach DevelopmentCurrent Issues in Molecular Biology 2024; 46(7): 6300 doi: 10.3390/cimb46070376